Education
About Us
Working with TipRanks
Follow Us
Chemours Company (CC)
:CC
CC Analyst Ratings
Strong Buy
6 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CC Stock 12 Month Forecast
Average Price Target
$17.13
▲(9.39% Upside)
| Highest Price Target$21.00 | Average Price Target$17.13 | Lowest Price Target$15.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Morgan Stanley
$15
Hold
-4.21%
Downside
Reiterated
09/26/25
Chemours Company: Hold Rating Amid Revised EPS and EBITDA ForecastsWe update our estimates for Chemours (CC) ahead of 3Q25 reporting. 3Q25 EPS is unchanged at $0.20 (vs. $0.28 consensus), 2025 is revised from $1.15 to $1.09 (vs. $1.26 consensus), 2026 is revised from $1.97 to $1.75 (vs. $2.12 consensus), and 2027 is revised from $2.38 to $2.61 (vs. $2.59 consensus). 3Q25 EBITDA is unchanged at $185M (vs. $175M-$195M guidance; $191M consensus), 2025 EBITDA is revised from $800M to $788M (vs. $775M-$825M guidance; $793M consensus), 2026 EBITDA is revised from $947M to $907M (vs. $942M consensus), and 2027 EBITDA is revised from $1,026M to $1,071M (vs. $1,037M consensus).
Truist Financial
$21
Buy
34.10%
Upside
Reiterated
09/26/25
Mizuho Securities
$16→$19
Buy
21.33%
Upside
Reiterated
09/23/25
Alembic Global
$20
Buy
27.71%
Upside
Reiterated
09/15/25
TR | OpenAI - 4o
$14.5→$15
Hold
-4.21%
Downside
Reiterated
08/19/25
AI Generated ArticleAI Generated Article
J.P. Morgan
$13→$15
Hold
-4.21%
Downside
Reiterated
08/14/25
BMO Capital
$15
Buy
-4.21%
Downside
Reiterated
08/13/25
RBC Capital
$15
Buy
-4.21%
Downside
Reiterated
08/08/25
UBS
$17
Buy
8.56%
Upside
Reiterated
07/01/25
Barclays
$16→$13
Hold
-16.99%
Downside
Reiterated
05/28/25
Goldman Sachs
$21→$14
Hold
-10.60%
Downside
Reiterated
05/14/25
Jefferies
$20→$11.5
Hold
-26.56%
Downside
Reiterated
05/08/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Morgan Stanley
$15
Hold
-4.21%
Downside
Reiterated
09/26/25
Chemours Company: Hold Rating Amid Revised EPS and EBITDA ForecastsWe update our estimates for Chemours (CC) ahead of 3Q25 reporting. 3Q25 EPS is unchanged at $0.20 (vs. $0.28 consensus), 2025 is revised from $1.15 to $1.09 (vs. $1.26 consensus), 2026 is revised from $1.97 to $1.75 (vs. $2.12 consensus), and 2027 is revised from $2.38 to $2.61 (vs. $2.59 consensus). 3Q25 EBITDA is unchanged at $185M (vs. $175M-$195M guidance; $191M consensus), 2025 EBITDA is revised from $800M to $788M (vs. $775M-$825M guidance; $793M consensus), 2026 EBITDA is revised from $947M to $907M (vs. $942M consensus), and 2027 EBITDA is revised from $1,026M to $1,071M (vs. $1,037M consensus).
Truist Financial
$21
Buy
34.10%
Upside
Reiterated
09/26/25
Mizuho Securities
$16→$19
Buy
21.33%
Upside
Reiterated
09/23/25
Alembic Global
$20
Buy
27.71%
Upside
Reiterated
09/15/25
TR | OpenAI - 4o
$14.5→$15
Hold
-4.21%
Downside
Reiterated
08/19/25
AI Generated ArticleAI Generated Article
J.P. Morgan
$13→$15
Hold
-4.21%
Downside
Reiterated
08/14/25
BMO Capital
$15
Buy
-4.21%
Downside
Reiterated
08/13/25
RBC Capital
$15
Buy
-4.21%
Downside
Reiterated
08/08/25
UBS
$17
Buy
8.56%
Upside
Reiterated
07/01/25
Barclays
$16→$13
Hold
-16.99%
Downside
Reiterated
05/28/25
Goldman Sachs
$21→$14
Hold
-10.60%
Downside
Reiterated
05/14/25
Jefferies
$20→$11.5
Hold
-26.56%
Downside
Reiterated
05/08/25
Best Analysts Covering Chemours Company
1 Month
xxx
Success Rate
15/24 ratings generated profit
Average Return
+4.68%
reiterated a xxx
rating 15 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 62.50% of your transactions generating a profit, with an average return of +4.68% per trade.
3 Months
xxx
Success Rate
14/24 ratings generated profit
Average Return
+7.85%
reiterated a xxx
rating 15 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 58.33% of your transactions generating a profit, with an average return of +7.85% per trade.
1 Year
Success Rate
14/24 ratings generated profit
Average Return
+6.18%
reiterated a buy rating 15 days ago
Copying Hassan Ahmed's trades and holding each position for 1 Year would result in 58.33% of your transactions generating a profit, with an average return of +6.18% per trade.
2 Years
xxx
Success Rate
12/24 ratings generated profit
Average Return
-0.68%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -0.68% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CC Analyst Recommendation Trends
Rating
May 25
Jun 25
Jul 25
Aug 25
Sep 25
Strong Buy
9
9
6
4
1
Buy
7
6
9
9
14
Hold
11
13
16
14
11
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
27
28
31
27
26
Each month's total comprises the sum of three months' worth of ratings.
CC Financial Forecast
CC Stock Forecast FAQ
What is CC’s average 12-month price target, according to analysts?
Based on analyst ratings, Chemours Company’s 12-month average price target is 17.13.
What is CC’s upside potential, based on the analysts’ average price target?
Chemours Company has 9.39% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CC a Buy, Sell or Hold?
Chemours Company has a consensus rating of Strong Buy which is based on 6 buy ratings, 2 hold ratings and 0 sell ratings.
What is Chemours Company’s price target?
The average price target for Chemours Company is 17.13. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $21.00 ,the lowest forecast is $15.00. The average price target represents 9.39% Increase from the current price of $15.66.
The highest analyst price target is $21.00 ,the lowest forecast is $15.00. The average price target represents 9.39% Increase from the current price of $15.66.
What do analysts say about Chemours Company?
Chemours Company’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.
How can I buy shares of CC?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.